Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Journal: Nature

Published: 2016-05-02

DOI: 10.1038/nature17676

Affiliations: 50

Authors: 88

Go to article

Research Highlight

Detailed genetic picture of breast cancer revealed

© SEBASTIAN KAULITZKI/Science Photo Library

© SEBASTIAN KAULITZKI/Science Photo Library

An international team has uncovered the most detailed evidence yet that the genetic profiles of breast cancers are highly specific to each patient. This finding represents a step towards bespoke cancer treatment based on an individual’s cancer genome.

In a study published in Nature, researchers analysed the whole genomes of 560 breast tumours, identifying 93 mutated cancer genes that were implicated in the genesis of breast cancer, including five previously unknown genes. They also found that the tumors of women carrying the BRCA1 or BRCA2 genes were genetically distinct from each other and from other breast cancers.

The study’s authors note that this information could one day help direct doctors to the most effective treatment for cancer sufferers.

"In the future, we'd like to be able to profile individual cancer genomes so that we can identify the treatment most likely to be successful for a woman or man diagnosed with breast cancer. It is a step closer to personalized healthcare for cancer," said lead author Serena Nik-Zainal from the Wellcome Trust Sanger Institute in a statement.

The multi-centre team included researchers from The University of Texas MD Anderson Cancer Center.

Supported content

  1. Nature 2016; 534, 47–54. doi: 10.1038/nature17676
Institutions FC WFC
Wellcome Trust Sanger Institute, United Kingdom (UK) 0.30 0.30
Cancer GenomiCs.nl (CGC.nl), Netherlands 0.06 0.06
The Netherlands Cancer Institute (NKI), Netherlands 0.03 0.03
Center for Oncological Research (CORE), UA, Belgium 0.03 0.03
Department of Clinical Sciences - Lund, LU, Sweden 0.03 0.03
Morgan Welch Inflammatory Breast Cancer Clinic, MD Anderson Cancer Center, United States of America (USA) 0.02 0.02
Faculty of Science, RU, Netherlands 0.02 0.02
College of Medicine, HYU, South Korea 0.02 0.02
UiO K.G. Jebsen Centre for Breast Cancer Research, Norway 0.02 0.02
Academic Medical Center (AMC), UvA, Netherlands 0.02 0.02
Faculty of Medicine, University of Iceland, Iceland 0.02 0.02
Institute Jules Bordet, ULB, Belgium 0.02 0.02
Asan Medical Center (AMC), South Korea 0.02 0.02
Synergie Lyon Cancer, France 0.02 0.02
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.02 0.02
UiO Institute for Cancer Research, Norway 0.02 0.02
Ninewells Hospital and Medical School, United Kingdom (UK) 0.02 0.02
Department of Pathology, BWH, United States of America (USA) 0.02 0.02
Faculty of Medicine and Biomedical Sciences (MBS), UQ, Australia 0.02 0.02
IRCCS National Cancer Institute (INT) Bari, Italy 0.01 0.01
Centre Léon Bérard (CLB), France 0.01 0.01
GZA Ziekenhuizen, Belgium 0.01 0.01
Department of Genetics and Developmental Biology, France 0.01 0.01
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.01 0.01
Radboud University Medical Centre (Radboudumc), RU, Netherlands 0.01 0.01
Institut Régional du Cancer de Montpellier (ICM), France 0.01 0.01
Department of Biomedical Engineering (BME), HYU, South Korea 0.01 0.01
Host-Graft-Tumor Interaction, Cell and Gene Engineering, France 0.01 0.01
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.01 0.01
Clinical Sciences Centre, CLB, France 0.01 0.01
Gachon University Gil Medical Center, South Korea 0.01 0.01
European Bioinformatics Institute (EMBL-EBI), United Kingdom (UK) 0.01 0.01
Wellcome Trust Genome Campus, United Kingdom (UK) 0.01 0.01
French National Cancer Institute (INCa), France 0.01 0.01
Haukeland University Hospital, Norway 0.01 0.01
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.01 0.01
INRIA Grenoble - Rhône-Alpes Research Centre, France 0.01 0.01
Singapore General Hospital (SGH), Singapore 0.01 0.01
National Cancer Centre Singapore (NCCS), Singapore 0.01 0.01
ICR Breast Cancer Now Toby Robins Research Centre, United Kingdom (UK) 0.01 0.01
Department of Clinical Science (K2), UIB, Norway 0.01 0.01
Faculty of Life Sciences and Medicine (LSM), KCL, United Kingdom (UK) 0.01 0.01
Biomedical Sciences Group, KU Leuven, Belgium 0.01 0.01
UiO Faculty of Mathematics and Natural Sciences, Norway 0.01 0.01
Cambridge University Hospitals NHS Foundation Trust, United Kingdom (UK) 0.01 0.01
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.01 0.01
Center for Nonlinear Studies (CNLS), LANL, United States of America (USA) 0 0
Theoretical Biology and Biophysics (T-6), LANL, United States of America (USA) 0 0
Royal Brisbane and Women's Hospital (RBWH), Australia 0 0
Pathology Queensland, Australia 0 0

Return